Up till now you were testing solutions on traditional platforms but on Magnisense’s MIAtek technology magnetic heads are used as markers rather than the traditional fluorescent or enzymatic methods which ensure that the biological target is identified in an accurate manner. It ensures that companies willing to use MIAtek in their applications can develop tests quickly which can be adapted as per the desired markers.
With this technology companies will be able to realize numerous advantages for themselves such as quantification of fast testing and increased sensitivity. The company had developed this platform on a joint basis with Indicia Biotechnology. This has opened up a number of opportunities for companies related to life sciences or diagnostics.
Luc Lenglet, CEO, Magnisense stated:
Before or after acquiring a license from Magnisense, any of our customers can now rapidly judge the value of our technology thanks to our jointly-developed tests. Indicia brings two indispensable skills to the development of MIAtek technology: immunoassays and reagents for the magnetic beads
Via scientistslive
